Company profile
Calla Lily Clinical Care Ltd
Innovators in Vaginal Drug Delivery | Calla Lily Clinical Care
Supporting fertility, pregnancy, ahealthy vaginal microbiome and other gynaecological conditions
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzUyNjE4NDg2OGFkaXF6a2N4
Published 10 Jun 2026 09:53
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Development of a women-centric gynaecological drug delivery device to improve psychosocial and physical wellbeing during treatment for miscarriage & pre-term birth prevention, and IVF
1 Apr 2023 to 31 Mar 2025
Calla Lily Clinical Care (CLCC) is an ambitious British startup that has successfully invented a novel hybrid tampon and pantyliner that can be designed in such a way that it delivers drugs to a woman's vagina when in place. The current way of delivering drugs to the vagina is to use a pessary, but these are inconvenient, unhygienic, prone to movement suc...
Overcoming pre-clinical challenges for a next-generation gynaecological drug delivery device which maximises patient comfort and convenience
1 Nov 2021 to 31 Oct 2022
Callaly is an ambitious British startup that has successfully developed and commercialised the first major innovation to the tampon in decades: a novel "hybrid" tampon and pantyliner that is the brainchild of a senior British gynaecologist. Called a Tampliner(R), the already multi award-winning product includes enhanced leakage prevention properties and a...